Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File) Yes, the Sacklers should pay a lot more for their releases. But the plan must be evaluated in light of the alternative, not in light of the ideal. (AP Photo/Douglas Healey, File)

On Sept. 1, 2021, Judge Drain confirmed Purdue Pharma’s restructuring plan. The plan is the culmination of roughly two years of legal wrangling by 48 states, thousands of municipalities, Indian tribes, and tens of private-side parties, each with a stake in the outcome of the case.

Politicians, advocates and academics have assailed the bankruptcy plan as a travesty of justice because, under the plan, the Sacklers will be released from civil liability and will not be held criminally accountable.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.